SUBSCRIBE
SUBSCRIBE

Pennsylvania

3D rendering of a T-cell
Approvals
Adaptimmune’s Tecelra Becomes First FDA-Approved Engineered Cell Therapy for Solid Tumors
Approved under the regulator’s accelerated pathway, Tecelra is also the first new synovial sarcoma therapy in more than a decade, according to Adaptimmune Therapeutics.
August 2, 2024
 · 
2 min read
 · 
Tristan Manalac
A 3D illustration of an antibody binding to human cell receptors
Series A
J&J Alums Raise $165M Series A for Startup to Develop Biologics for Cancer, Autoimmune Diseases
Third Arc Bio, led by three former Johnson & Johnson executives, is advancing a portfolio of multifunctional antibodies for cancer and inflammatory and immune-mediated diseases.
July 24, 2024
 · 
2 min read
 · 
Tristan Manalac
3D illustration of a T cell killing a cancer cell
CAR-T
Interius Gets Go-Ahead for Phase I Trial of In Vivo CAR-T Therapy in Australia
Interius BioTherapeutics has received approval from Australia’s Human Research Ethics Committee to begin the first-in-human trial of an investigational in vivo CAR-T therapy designed to treat B-cell malignancies.
July 10, 2024
 · 
2 min read
 · 
Tristan Manalac
Load More
PRESS RELEASES
Press Releases
Certara to Report Fourth Quarter and Full Year 2025 Financial Results on February 26th, 2025
January 29, 2026
 · 
1 min read
Press Releases
Aspire Biopharma Secures Agreement with Microsize for Development of Novel Sublingual Aspirin
January 29, 2026
 · 
6 min read
Press Releases
Aprea Therapeutics Announces Early Clinical Proof-Of-Concept in the Ongoing ACESOT-1051 Dose-Escalation Trial Evaluating WEE1 Inhibitor APR-1051, Including Partial Response Observed on First Scan
January 29, 2026
 · 
7 min read
Press Releases
Aprea Therapeutics Announces $5.6 Million Private Placement Priced At-The-Market Under Nasdaq Rules
January 29, 2026
 · 
5 min read
Press Releases
West to Host Fourth-Quarter and Full-Year 2025 Conference Call
January 29, 2026
 · 
1 min read
Press Releases
FDA Qualifies MolecuLightDX Wound Measurement as a Medical Device Development Tool (MDDT) for Evaluating New Products in Wound Care
January 29, 2026
 · 
2 min read
Press Releases
Unravel Biosciences and The SCN2A Foundation Announce Drug Discovery Collaboration
January 29, 2026
 · 
2 min read
Press Releases
Olympus Announces U.S. Launch of the SecureFlex™ Single-Use Fine Needle Biopsy Device
January 29, 2026
 · 
4 min read
Press Releases
BriaCell Patients’ Images Show Regression and Resolution of Metastasized Tumors and Immune Activation
January 29, 2026
 · 
6 min read
Press Releases
Fujirebio Expands Its Neuro Testing Portfolio With the Launch of the Fully Automated Lumipulse® G pTau 217 CSF Assay for Research Use Only
January 28, 2026
 · 
2 min read
Press Releases
DARZALEX FASPRO®-based quadruplet regimen approved in the U.S. for newly diagnosed patients with multiple myeloma who are transplant ineligible
January 28, 2026
 · 
24 min read
Press Releases
Savara Announces Amendment to Hercules Capital Debt Facility Providing up to $75M of Additional Debt Funding Upon U.S. Food and Drug Administration (FDA) Approval of MOLBREEVI*
January 28, 2026
 · 
6 min read
Press Releases
Orchestra Life Sciences Expands into Europe to Support Radiopharmaceutical Execution, Appoints Vinod Ramnandanlal as President and Managing Director
January 28, 2026
 · 
3 min read
Press Releases
Minaris Announces Viral Clearance Laboratory Upgrade at Philadelphia Campus
January 28, 2026
 · 
3 min read
Press Releases
BriaCell Highlights Extended >18-47 Months Survival in Phase 2 Metastatic Breast Cancer Patients
January 28, 2026
 · 
6 min read
Press Releases
Aclaris Therapeutics’ Novel ITK/JAK3 Inhibitor ATI-2138 Demonstrates Rapid and Sustained Hair Regrowth in Validated Murine Model of Alopecia Areata (AA)
January 27, 2026
 · 
6 min read
Press Releases
Traws Pharma Completes Enrollment of Ratutrelvir Clinical Study in PAXLOVID®-Eligible and Ineligible COVID-19 Patients; Announces Plans for Added Indication for Tivoxavir Marboxil as a Prophylactic Treatment for Seasonal Influenza
January 27, 2026
 · 
9 min read
Press Releases
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - January 23, 2026
January 26, 2026
 · 
2 min read
Press Releases
Ocugen, Inc. Announces Closing of $22.5 Million Underwritten Registered Direct Offering of Common Stock
January 26, 2026
 · 
3 min read
Press Releases
Alveus Therapeutics Announces FDA Clearance of IND and First Patient Dosed in Phase 1b Trial of ALV-100 for Obesity
January 26, 2026
 · 
2 min read
Load More